7-92447825-T-G
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The NM_021167.5(GATAD1):āc.96T>Gā(p.His32Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000149 in 1,471,886 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_021167.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GATAD1 | NM_021167.5 | c.96T>G | p.His32Gln | missense_variant | 1/5 | ENST00000287957.5 | NP_066990.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GATAD1 | ENST00000287957.5 | c.96T>G | p.His32Gln | missense_variant | 1/5 | 1 | NM_021167.5 | ENSP00000287957 | P1 | |
GATAD1 | ENST00000645746.1 | c.96T>G | p.His32Gln | missense_variant, NMD_transcript_variant | 1/6 | ENSP00000493785 | ||||
TMBIM7P | ENST00000641474.1 | upstream_gene_variant | ||||||||
GATAD1 | ENST00000644160.1 | upstream_gene_variant |
Frequencies
GnomAD3 genomes AF: 0.000973 AC: 148AN: 152108Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000474 AC: 4AN: 84424Hom.: 0 AF XY: 0.0000212 AC XY: 1AN XY: 47160
GnomAD4 exome AF: 0.0000546 AC: 72AN: 1319670Hom.: 1 Cov.: 31 AF XY: 0.0000538 AC XY: 35AN XY: 650646
GnomAD4 genome AF: 0.000972 AC: 148AN: 152216Hom.: 0 Cov.: 33 AF XY: 0.000887 AC XY: 66AN XY: 74424
ClinVar
Submissions by phenotype
Dilated cardiomyopathy 2B Uncertain:1Benign:1
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Genomics, Ann and Robert H. Lurie Children's Hospital of Chicago | Mar 30, 2021 | GATAD1 NM_021167.4 exon 1 p.His32Gln (c.96T>G): This variant has not been reported in the literature but is present in 0.3% (34/10848) of African alleles in the Genome Aggregation Database (http://gnomad.broadinstitute.org/variant/7-92077139-T-G). This variant is present in ClinVar (Variation ID:228696). Evolutionary conservation for this variant is limited or unavailable; computational predictive tools suggest that this variant may not impact the protein. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 04, 2023 | - - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jan 05, 2015 | The p.His32Gln variant in GATAD1 has not been previously reported in individuals with cardiomyopathy, but has been identified in 0.2% (2/1260) of African Americ an chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinsti tute.org; dbSNP rs532003876). Computational prediction tools and conservation an alysis do not provide strong support for or against an impact to the protein. In summary, the clinical significance of the p.His32Gln variant is uncertain. - |
Cardiovascular phenotype Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 10, 2023 | The p.H32Q variant (also known as c.96T>G), located in coding exon 1 of the GATAD1 gene, results from a T to G substitution at nucleotide position 96. The histidine at codon 32 is replaced by glutamine, an amino acid with highly similar properties. This variant was reported in a sudden death case with limited clinical details provided (Subbotina E et al. Forensic Sci Int, 2018 Dec;293:37-46). This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
GATAD1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 09, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 08, 2020 | This variant is associated with the following publications: (PMID: 30391667) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at